Page 1445 - Williams Hematology ( PDFDrive )

1420 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1421

294. Mrózek K, Heinonen K, Lawrence D, et al: Adult patients with de novo acute mye- 326. Bratt G, Bromback M, Paul C, et al: Factors and inhibitors of blood coagulation and
loid leukemia and t(9;11) (p22;q23) have a superior outcome to patients with other fibrinolysis in acute nonlymphoblastic leukaemia. Scand J Haematol 34:332, 1985.
translocations involving band 11q23: A Cancer and Leukemia Group B study. Blood 327. Reddy VB, Kowal-Vern A, Hoppensteadt DA, et al: Global and molecular hemostatic
90:4532, 1997. markers in acute myeloid leukemia. Am J Clin Pathol 94:397, 1990.
295. Swansbury GJ, Slater R, Bain BJ, et al: Hematologic malignancies with t(9;11) (p21–22; 328. Tsumita Y, Matsushima T, Uchiumi H, et al: Acute myeloid leukemia accompanied by
q23)—A laboratory and clinical study of 125 cases. Leukemia 12:792, 1998. multiple thrombophlebitis. Intern Med 36:595, 1997.
296. Huret JL, Dessen P, Bernheim A: An atlas of chromosomes in hematological malig- 329. Weltermann A, Pabinger I, Geiseler K, et al: Hypofibrinogenemia in non-M3 acute
nancies. Example: 11q23 and MLL partners. Leukemia 15:987, 2001. myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis.
297. Scholl C, Breitinger H, Schlenk RF, et al: Development of a real-time RT-PCR assay Leukemia 12:1182, 1998.
for the quantification of the most frequent MLL/AF9 fusion types resulting from 330. Greenwood MJ, Seftel MD, Richardson C, et al: Leukocyte count as a predictor of
translocation t(9;11)(p22;q23) in acute myeloid leukemia. Genes Chromosomes Can- death during remission induction in acute myeloid leukemia. Leuk Lymphoma 47:
cer 38:274, 2003. 1245, 2006.
298. Meyer C, Schneider B, Jakob S, et al: The MLL recombinome of acute leukemias. 331. Lichtman MA, Heal J, Rowe JM: Hyperleukocytic leukaemia: Rheological and clinical
Leukemia 20:777, 2006. features and management. Baillieres Clin Haematol 1:725, 1987.
299. Soupir CP, Vergilio JA, Dal Cin P, et al: Philadelphia chromosome-positive acute 332. Nowacki P, Zdziarska B, Fryze C, Urasinski I: Co-existence of thrombocytopenia and
myeloid leukemia: A rare aggressive leukemia with clinicopathologic features distinct hyperleukocytosis (“critical period”) as a risk factor of haemorrhage into the central
from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 127:642, nervous system in patients with acute leukaemias. Haematologia (Budap) 31:347, 2002.
2007. 333. Wurthner JU, Kohler G, Behringer D, et al: Leukostasis followed by hemorrhage
300. Tien HF, Wang CH, Chuang SM, et al: Characterization of Philadelphia-chromo- complicating the initiation of chemotherapy in patients with acute myeloid leukemia
some-positive acute leukemia by clinical, cytochemical, and gene analysis. Leukemia and hyperleukocytosis: A clinicopathologic report of four cases. Cancer 85:368,
6:907, 1992. 1999.
301. Duchayne E, Fenneteau O, Pages MP, et al: Acute megakaryoblastic leukaemia: A 334. Ventura GJ, Hester JP, Smith TL, Keating MJ: Acute myeloblastic leukemia with
national clinical and biological study of 53 adult and childhood cases by the Groupe hyperleukocytosis: Risk factors for early mortality in induction. Am J Hematol 27:34,
Français d’Hématologie Cellulaire (GFHC). Leuk Lymphoma 44:49, 2003. 1988.
302. Borel C, Dastugue N, Cances-Lauwers V, et al: PICALM-MLLT10 acute myeloid leu- 335. Dutcher J, Schiffer CA, Wiernik PH: Hyperleukocytosis in adult acute nonlympho-
kemia: A French cohort of 18 patients. Leuk Res 36:1365, 2012. cytic leukemia: Impact on remission rate, duration, and survival. J Clin Oncol 5:1364,
303. Billstrom R, Ahlgren T, Bekassy AN, et al: Acute myeloid leukemia with inv(16) 1987.
(p13q22): Involvement of cervical lymph nodes and tonsils is common and may be a 336. VanBuchem MA, Te Velde J, Willemze R, Spaander PJ: Leucostasis, an underesti-
negative prognostic sign. Am J Hematol 71:15, 2002. mated cause of death in leukaemia. Blut 56:39, 1988.
304. Speck NA, Gilliland DG: Core-binding factors in haematopoiesis and leukaemia. Nat 337. Dilek I, Uysal A, Demirer T, et al: Acute myeloblastic leukemia associated with hyper-
Rev Cancer 2:502, 2002. leukocytosis and diabetes insipidus. Leuk Lymphoma 30:657, 1998.
305. Delauney J, Ve3y N, Leblanc T, et al: Prognosis of Inv 16/t(16;16) acute myeloid leuke- 338. Lavabre-Bertrand T, Bourquard P, Chiesa J, et al: Diabetes insipidus revealing acute
mia (AML): A survey of 110 cases from the French AML Intergroup. Blood 102:462, myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of
2003. chromosome 3: A new entity? Eur J Haematol 66:66, 2001.
306. Poirel H, Radford-Weiss I, Rack K, et al: Detection of the chromosome 16 CBFβ- 339. Inaba H, Fan Y, Pounds S, et al: Clinical and biologic features and treatment outcome
MYH11 fusion transcript in myelomonocytic leukemias. Blood 85:1313, 1995. of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
307. Haferlach T, Winkemann M, Löffler H, et al: The abnormal eosinophils are part of the Cancer 113:522, 2008.
leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils 340. Bug G, Anargyrou K, Tonn T, et al: Impact of leukapheresis on early death rate in adult
(AML M4 Eo) and carry pericentric inversion 16: A combination of May-Grünwald- acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 47:1843,
Giemsa a staining and fluorescence in situ hybridization. Blood 87:2459, 1996. 2007.
308. Secker-Walker LM, Mehta A, Bain B: Abnormalities of 3q21 and 3q26 in myeloid 341. Nagler A, Brenner B, Zuckerman E, et al: Acute respiratory failure in hyperleukocytic
malignancy: A United Kingdom Cancer Cytogenetic Group study. Br J Haematol acute myeloid leukemia. Am J Hematol 27:65, 1988.
91:490, 1995. 342. Von Eyben FE, Siddiqui MZ, Spanosi G: High-voltage irradiation and hydroxyurea
309. Marcucci G, Radmacher MD, Maharry K, et al: MicroRNA expression in cytogeneti- for pulmonary leukostasis in acute myelomonocytic leukemia. Acta Haematol 77:180,
cally normal acute myeloid leukemia. N Engl J Med 358:1919, 2008. 1987.
310. Haferlach T, Kohlmann A, Wieczorek L, et al: Clinical utility of microarray-based 343. Azoulay E, Fieux F, Moreau D, et al: Acute monocytic leukemia presenting as respira-
gene expression profiling in the diagnosis and subclassification of leukemia: Report tory failure. Am J Respir Crit Care Med 167:1329, 2003.
from the international microarray innovations in leukemia study group. J Clin Oncol 344. Koote AMM, Thompson J, Bruijn JA: Acute myelocytic leukemia with acute aortic
28:2529, 2010. occlusion as presenting symptoms. Acta Haematol 75:120, 1986.
311. Kjellstrand CM, Campbell DC, Von Hartitzsch B, Buselmeier TJ: Hyperuricemic 345. Foss R, Haddad M, Zaizov R, et al: Recurrent peripheral arterial occlusion by leu-
acute renal failure. Arch Intern Med 133:349, 1974. kemic cells sedimentation in acute promyelocytic leukemia. J Pediatr Surg 27:665,
312. O’Regan S, Carson S, Chesney RW, Drummond KN: Electrolyte and acid–base distur- 1992.
bances in the management of leukemia. Blood 49:345, 1977. 346. Mataix R, Gómez-Casares MT, Campo C, et al: Acute leg ischaemia as a presentation
313. Mir MA, Delamore IW: Metabolic disorders in acute myeloid leukaemia. Br J Haema- of hyperleukocytosis syndrome in acute myeloid leukaemia. Am J Hematol 51:250,
tol 40:79, 1978. 1996.
314. Bergman GE, Baluarte HJ, Naiman JL: Diabetes insipidus as a presenting manifesta- 347. Murray JC, Dorfman SR, Brandt ML, Dreyer ZE: Renal venous thrombosis complicat-
tion of acute myelogenous leukemia. J Pediatr 88:355, 1976. ing acute myeloid leukemia in the hyperleukocytosis. J Pediatr Hematol Oncol 18:327,
315. Mir MA, Brabin B, Tang OT, et al: Hypokalemia in acute myeloid leukaemia. Ann 1996.
Intern Med 82:54, 1975. 348. Cohen Y, Amir G, Da’as N, et al: Acute myocardial infarction as the presenting symp-
316. Salomon J: Spurious hypoglycemia and hyperkalemia in myelomonocytic leukemia. tom of acute myeloblastic leukemia with extreme hyperleukocytosis. Am J Hematol
Am J Med Sci 267:359, 1974. 71:47, 2002.
317. Bellevue R, Disik H, Speigel G, Gussoff BD: Pseudohyperkalemia and extreme leuko- 349. Zhang W, Zhang X, Fan X, et al: Effect of ICAM-1 and LFA-1 in hyperleukocytic acute
cytosis. J Lab Clin Med 85:660, 1975. myeloid leukaemia. Clin Lab Haematol 28:177, 2006.
318. Fox MJ, Brody JS, Weintraub LR, et al: Leukocyte larceny: A cause of spurious hypoxia. 350. Berdeaux DH, Glosser L, Serokmann R: Hypoplastic acute leukemia. Review of 70
Am J Med 67:742, 1979. cases with multivariate regression analysis. Hematol Oncol 4:291, 1986.
319. Palva IP, Salokannel SJ: Hypercalcemia in acute leukemia. Blut 24:209, 1972. 351. Tuzuner N, Cox C, Rowe JM, Bennett JM: Hypocellular acute leukemia. Hematol Pathol
320. Zidar BL, Shadduck RK, Winkelstein A, et al: Acute myeloblastic leukemia and hyper- 9:195, 1995.
calcemia. N Engl J Med 295:692, 1976. 352. Nagai K, Kohno T, Chen Y-X, et al: Diagnostic criteria for hypocellular acute leuke-
321. Roth GJ, Poite D: Chronic lactic acidosis and acute leukemia. Arch Intern Med mia. Leuk Res 7:563, 1996.
125:317, 1970. 353. Bennett JM, Orazi A: Diagnostic criteria to distinguish hypocellular acute myeloid
322. Wainer RA, Wiernik PH, Thompson WL: Metabolic and therapeutic studies of a leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: Recom-
patient with acute leukemia and severe lactic acidosis of prolonged duration. Am J mendations for a standardized approach. Haematologica 94:264, 2009.
Med 55:255, 1973. 354. Iwakiri R, Ohta M, Mikoshiba M, et al: Prognosis of elderly patients with acute myel-
323. Zamkoff KW, Kirshner JJ: Marked hypophosphatemia associated with acute myelo- ogenous leukemia: Analysis of 126 AML cases. Int J Hematol 75:45, 2002.
monocytic leukemia. Arch Intern Med 140:1523, 1980. 355. Niissler V, Sauer H, Pelka-Fleischer R, et al: Clinical, biochemical and cytokinetic
324. Pflüger K-H, Gramse M, Gropp C, Havemann K: Ectopic ACTH production with parameters for distinguishing smouldering and rapidly proliferating variants of acute
autoantibody formation in a patient with acute myeloblastic leukemia. N Engl J Med leukaemia. Eur J Haematol 45:19, 1990.
305:1632, 1981. 356. Paietta E, Racevskis J, Bennett JM, et al: Biologic heterogeneity in Philadelphia chro-
325. Carpenter NA, Fiere DM, Schuh D, et al: Circulating immune complexes and the mosome-positive acute leukemia with myeloid morphology. Leukemia 12:1881,
prognosis of acute myeloid leukemia. N Engl J Med 307:1174, 1982. 1998.

Kaushansky_chapter 88_p1373-1436.indd 1420 9/21/15 11:02 AM